World Equity Group’s Zomedica Corp. ZOM Stock Holding History

World Equity Group’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40,000	Closed	-$4.8K	–	395
2024 Q4	$4.8K	Hold	40,000	–	–	﹤0.01%	358
2024 Q3	$5.49K	Hold	40,000	–	–	﹤0.01%	256
2024 Q2	$5.85K	Hold	40,000	–	–	﹤0.01%	268
2024 Q1	$5.84K	Buy	40,000 +10,000	+33%	+$1.4K	﹤0.01%	308
2023 Q4	$6.01K	Hold	30,000	–	–	﹤0.01%	327
2023 Q3	$5.01K	Hold	30,000	–	–	﹤0.01%	334
2023 Q2	$6K	Buy	+30,000	New	+$6.09K	﹤0.01%	317
2023 Q1	–	Sell	-22,500	Closed	-$3.67K	–	605
2022 Q4	$3.67K	Hold	22,500	–	–	﹤0.01%	328
2022 Q3	$4.75K	Buy	22,500 +2,500	+13%	+$662	﹤0.01%	319
2022 Q2	$4.4K	Hold	20,000	–	–	﹤0.01%	332
2022 Q1	$6.74K	Buy	+20,000	New	+$6.54K	﹤0.01%	357

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

JWM

Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

World Equity Group's ZOM Position: Q1 2025 in Review

World Equity Group sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 40,000 shares — an estimated $4.8K sold.

World Equity Group first reported a position in ZOM in Q1 2022 and held it in 11 quarters. The position peaked at $6.74K in Q1 2022. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

World Equity Group reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
World Equity Group sold 40,000 Zomedica Corp. shares in Q1 2025, an estimated $4.8K.
World Equity Group first reported a position in Zomedica Corp. in Q1 2022 and held it in 11 quarters.
World Equity Group's Zomedica Corp. position peaked at $6.74K in Q1 2022.
23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on World Equity Group's 13F filing for Q1 2025, filed 22 Apr 2025.